Mercury Lab Peer Comparison

BSE: 538964

₹755.00

₹-5.00 (-0.66%)

As on 16-Oct-2026IST

Market cap

₹91 Cr

Revenue (TTM)

₹74 Cr

P/E Ratio

21.8

P/B Ratio

1.6

Div. Yield

0.5 %

Edit

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	91	18,336	17,484	17,475	15,832
Revenue (₹ Cr)	74	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	4.16	273.51	678.07	735.15	666.92
Net Margin (%)	5.51	16.19	28.10	26.88	20.60
RoE (%)	7.80	11.15	19.73	19.16	18.75
Price to Earnings	21.76	61.67	26.28	23.77	24.59
Price-To-Book	1.55	6.83	4.76	3.97	3.93

Income Statement (₹ Cr)

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	73.76	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	75.59	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	65.88	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	7.88	478.55	796.58	941.63	1,139.61
Depreciation	3.31	126.01	78.10	57.58	281.06
EBIT	4.58	352.55	718.48	884.05	858.55
Interest	0.52	52.11	0.88	7.69	190.64
Other Income	1.83	7.37	125.96	165.62	7.45
Exceptional Items	-0.40	12.16	0.00	-49.16	-17.24
Profit before Tax	5.48	319.96	843.56	992.82	658.12
Provision for Tax	1.32	46.45	165.49	257.67	-8.80
Profit after Tax	4.16	273.51	678.07	735.15	666.92

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	58.08	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	9.32	266.35	28.74	91.50	1,392.75
Current Liabilities	11.69	848.06	385.94	627.48	2,077.10
Total Liabilities	74.24	3,310.68	3,207.85	4,911.11	6,865.52

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	32.78	2,525.44	1,291.22	770.28	5,617.77
Current Assets	44.95	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	74.24	3,310.68	3,207.85	4,911.11	6,865.52
Total Debt*	4.09	586.37	0.55	2.50	2,421.66
Net Current Assets	33.26	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	3.26	76.22	0.64	363.79	51.96

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	4.00	132.27	432.37	659.75	1,065.01
Cash Flow from Investing Activities	-9.04	-199.13	-334.73	-71.34	-79.97
Cash from Financing Activities	-0.99	62.65	-38.32	-205.34	-881.32
Net Cash Inflow / Outflow	-6.03	-4.21	59.32	383.07	103.72

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	9.14	6.95	26.22	26.21	13.59
ROE (%)	7.80	11.15	19.73	19.16	18.75
ROA (%)	5.43	7.80	18.69	14.95	9.26
EBIT Margin (%)	6.20	20.95	31.41	34.40	26.58
Net Margin (%)	5.51	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	-3.65	27.91	15.01	10.69	9.59
EBIT Growth (%)	-3.54	58.32	18.45	24.14	16.84
Net Profit Growth (%)	10.42	149.56	19.61	-9.09	62.68
EPS Growth (%)	17.74	-3.57	17.73	14.40	67.41
Book Value Growth (%)	5.37	30.63	23.77	17.30	10.19

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	20.41	65.42	26.28	22.65	23.97
Price / Book Value	1.55	6.83	4.76	3.97	3.93
Dividend Yield (%)	0.46	0.06	0.35	1.96	0.00
EV/EBITDA	11.74	39.60	20.69	15.26	15.86
Market Cap (₹ Cr)	98.28	6,484.12	15,219.80	18,318.10	19,292.77

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.12	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.01	0.13	0.00	0.00	0.14
Current Ratio	3.85	1.31	6.70	6.06	0.74
Quick Ratio	3.24	0.88	5.59	5.31	0.53
Interest Coverage	11.46	7.14	959.59	130.11	4.45

	Mercury Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	35.04	30.84	36.10	7.07	21.07
Asset Turnover	0.96	0.48	0.63	0.52	0.45
Receivable days	115.65	118.15	110.70	29.10	54.06
Inventory Days	32.60	98.29	65.86	69.53	32.16
Payable days	152.93	128.16	105.88	76.77	140.91
Cash Conversion Cycle	-4.69	88.28	70.68	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.